1Lazarescu GR, Battista JJ. Analysis of the radiobiolo gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[j]. Phys Med Biol, 1997,42:1727-1736.
2Ling CC. Permanent implams using Au-198, Pd-103and I-125: Radiobiological considerations based on the linear quadratic model [J]. Int J Radiat Oncol Biol Phys, 1992,23:81-87.
4Anderson LL, Kuan HM, Ding IY. Clinical dosimetry with I-125 [A]. In Gorge [ed]. Modern interstitial and intracavitary radation cancer management [C].New York : Masson Publishing, 1981.
5Williamson JF. Physics of brachythcrapy[A]. Perez CA, Brady LW[ed]. Principles and practice of radiation oncology [C]. Third Edition, Philadelphia: Lippincott -Raven, 1997.
6Nath R, Anderson LL, Meli JA, et al. Code of practice for brachytherapy physics: Report of the AAPM radation therpy committee task group NO. 56[J]. Med Phys, 1997,24:1557-1579.
7Wu A, Zwicker D, Sternick ES. Tumor dose specification of I-125 seed implants[J]. Med Phys, 1985,12:27-31.
8Chen Y, Stanton RE, Holst RJ, et al. Treatment planning for prostate implant with loose seeds [J].Med Phys,1997, 24:1141-1145.
9Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO. 43[J]. Med Phys,1995, 22:209-233.
10Williamson JF, Courscy BM, DeWerd LA, et al.Guidence to users of Nycomed Amersham and North American Scientific, Inc, I-125 interstitial sources:Dosimetry and calibration changes: Recommendations of the American Association of physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy[J]. Med Phys, 1999,26:570-573.
